Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Within the framework of the project “Cooperative Cohort COVID-19”, a mobile application will allow citizens to transfer their data under certain conditions and thus actively collaborate in research projects.

The grant will allow to carry out a validation study of a digital tool for monitoring patients with advanced diabetic kidney disease.

The analysis aimed to identify trends in indicators of quality of care in the surgical treatment of adult scoliosis, such as complications, reinterventions and impact on the quality of life of patients with spinal deviation.

Dr Albert Salazar, director of Vall d’Hebron and Chairman of the EUHA highlighted “the significance of this alliance, which allows us to establish synergies with Europe and thus improve patient care”.

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago.

Prostate cancer, testicle cancer, mental health and preventing suicide among men were the focus of the charity organisation Movember, which since 2003 has funded more than 1,250 projects associated with male health around the world.

The Fight Kids Cancer initiative (a union of three European cancer associations: Imagine for Margo, Kick Cancer and Kriibskrank Kanner Foundation) is the funding institution.

L’Associació Pulseras Candela consolida la seva col·laboració amb una nova aportació de 50.000€ al projecte del Dr. Miquel Segura i la Dra. Roberta Antonelli del VHIR.

As of tomorrow, Lleida will be hosting the 19th Congress of the Spanish Society of Neuroscience (SENC). This is a biennial event, which this year will be held from 3 to 5 November in la Llotja, the Lleida Exhibition Centre.

Hi participaran 300 persones en set centres repartits per tota Catalunya, entre els quals es troba Vall d'Hebron.

The Aligning Science Across Parkinson's (ASAP) initiative has awarded the grant to a project coordinated by Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at the Vall d'Hebron Research Institute (VHIR).

The funded project, led by Dr. Berta Sáez, will analyze the usefulness of certain biomarkers for the diagnosis and evaluation of disease progression.

El cap del Servei de Neurologia-Neuroimmunologia Clínica de l’Hospital Vall d’Hebron, cap del Grup d’Investigació en Neuroimmunologia Clínica del VHIR i director del Centre d'Esclerosi Múltiple de Catalunya (Cemcat) ha liderat el comitè d’elaboració de la guia europea amb recomanacions per a neuròlegs i pacients, basades en l’evidència existent, sobre l’eficàcia de tractaments, que ha presentat al Congrés del Comitè Europeu del Tractament i Recerca en Esclerosi Múltiple (ECTRIMS).

La Dra. Carmen Tur rebrà un ajut per al projecte “Caracterització de patrons espai temporals de dany tissular cerebral en esclerosi múltiple mitjançant tècniques d'aprenentatge profund no supervisat”.

La campanya vol sensibilitzar la ciutadania sobre la importància de la recerca i permet la seva col·laboració amb la Recerca de Vall d’Hebron a través de microdonatius.

A Vall d’Hebron, l'abordatge del càncer de mama es realitza de manera multidisciplinària: personal d'oncologia, radioteràpia i medicina nuclear i cirurgians i cirurgianes plàstics treballen de manera coordinada per definir el tractament més adient per a cada pacient.

Research led by Dr Fernando Azpiroz points to an increase in gas caused by high metabolic activity in the intestine.

Vall d’Hebron obre les portes gràcies al 48h Open House BCN 2021, que se celebra a Barcelona el cap de setmana del 23 i el 24 d’octubre i enguany està dedicat a l’arquitectura mediterrània. 

 El Campus del segle XXI s’està fent una realitat: s’han fet actuacions als edificis per adequar-los als nous reptes assistencials, s’està ordenant Vall d’Hebron i es guanyarà un parc per a la ciutat.

The associations have donated €32,130 towards the project entitled “Tinc una IDP; No estic sol” [“I have a PID; I’m not alone”]

This research has shown the efficacy of dual therapy for HIV treatment, with dolutegravir and lamivudine, compared with the standard treatment with three drugs.

The AGM was held between 6 and 8 October at Pompeu Fabra University, bringing together one hundred neuroblastoma experts.

Vall d’Hebron University Hospital diagnosed the first case of HIV in Spain in October 1981. This was a 35 year-old man who was admitted to hospital with Kaposi’s sarcoma and other opportunistic infections.

It would be a very rare and potentially fatal placental injury in some fetuses that would lead to abnormal blood flow between mothers and fetuses in the uterus.